HOMA-IR Explained: What Your Insulin Resistance Score Actually Means

What HOMA-IR measures — and why fasting glucose alone misses it

Two patients with identical fasting glucose of 95 mg/dL can have wildly different insulin resistance. The one pumping 25 μIU/mL of insulin to maintain that glucose has significant insulin resistance; the one at 8 μIU/mL does not. Fasting glucose alone tells you nothing about how hard the pancreas is working. HOMA-IR captures both values together — revealing the compensatory hyperinsulinemia that precedes glucose dysregulation by years.

The calculation explained

Formula: HOMA-IR = (fasting insulin [μIU/mL] × fasting glucose [mg/dL]) ÷ 405. The constant 405 is used when glucose is in mg/dL. For mmol/L units, divide by 22.5 instead. Both values must be drawn fasting — 10–12 hours, water only. Coffee, even black, raises insulin and invalidates the result. A single morning blood draw captures both values simultaneously.

Reference ranges and clinical thresholds

Clinical reference points — not diagnostic criteria for any specific disease: <1.0 is optimal insulin sensitivity. 1.0–1.9 is the normal range for most adults. 2.0–2.5 is borderline insulin resistance. 2.5–5.0 is significant insulin resistance. >5.0 is severe insulin resistance, often accompanied by fasting hyperinsulinemia. A HOMA-IR of 3.5 at age 35 means the metabolic dysfunction started years earlier — long before any glucose marker flagged it.

HOMA-IR and GLP-1 response prediction

Multiple cohort studies show patients with HOMA-IR >2.5 at baseline experience faster initial weight loss on semaglutide and tirzepatide. The hypothesized mechanism: higher baseline insulin resistance means more metabolic dysfunction to correct; GLP-1&apos;s glucose-lowering and insulin-sensitizing effect produces a larger relative improvement in this population. This does not mean high HOMA-IR is desirable — it means GLP-1 may provide greater metabolic benefit to those who need it most. At 24 weeks, this differential typically equalizes as insulin sensitivity normalizes.

Lifestyle interventions with outcome data

Low-carbohydrate diet (≤50g carbs/day): HOMA-IR reduction of 25–40% at 8 weeks in multiple RCTs — the largest dietary signal of any single intervention. Time-restricted eating (16:8 protocol): mean HOMA-IR reduction of 1.1 points at 12 weeks, independent of caloric restriction. Resistance training 3x/week: HOMA-IR reduction of 0.5–0.8 points at 12 weeks — muscle tissue is the primary site of peripheral glucose uptake. Combination (diet + resistance training): additive effects, up to 55% total HOMA-IR reduction. These are modifiable lifestyle changes with documented mechanistic evidence — not population correlations.

Medications that improve HOMA-IR

Metformin reduces hepatic glucose output and improves peripheral insulin sensitivity, with HOMA-IR reduction of approximately 20% in clinical trials. Berberine: meta-analysis shows similar HOMA-IR reduction to metformin at 500mg TID — acting through AMPK activation. GLP-1 agonists: reduce HOMA-IR by 30–50% at 24 weeks in T2D patients, with benefit seen even at early dose escalation stages. Inositol (myo-inositol): evidence specifically in PCOS patients; 4g/day produces significant HOMA-IR improvement, likely through insulin receptor second-messenger pathway effects. Reducing HOMA-IR from >3 to <1.5 is equivalent to a ~40% cardiovascular risk reduction in observational data.

How WellSpry tracks HOMA-IR

The WellSpry baseline panel includes fasting insulin and fasting glucose as standard. HOMA-IR is calculated automatically in results and presented in your physician report with interpretation. Quarterly retests track the trend — because a single HOMA-IR value is a snapshot; the trajectory is what matters clinically. A declining HOMA-IR confirms metabolic improvement independent of weight loss, which is important because GLP-1 improves insulin sensitivity measurably before significant weight loss occurs. Patients can observe metabolic improvement in the data weeks before the scale reflects it.

WellSpry's panel includes fasting insulin and glucose with HOMA-IR calculation and physician interpretation. Know your number before you start any metabolic protocol.

Frequently Asked Questions